Can Ultrasound Wearables Truly Transform Blood Pressure Monitoring?

January 16, 2025

The quest for accurate, convenient, and reliable blood pressure monitoring has long presented a challenge in the realm of wearable health-tracking devices. Traditional methods involving cuffs, despite their bulkiness and inconvenience, have remained the gold standard due to their precision. Wearable devices, while offering a more convenient and user-friendly experience, have struggled with accuracy when attempting to replicate these measurements. Enter Novosound’s groundbreaking development: a miniature ultrasound sensor that promises to transcend these hurdles. This innovation has culminated in Slanj, a sleek, wireless, cuffless wearable device poised to set a new benchmark in health monitoring through continuous blood pressure measurement. As Novosound unveils this technology at CES 2025, the potential implications for hypertension management and proactive healthcare interventions stand to be profound.

Challenges in Measuring Blood Pressure with Wearables

Wearable technology has revolutionized health tracking, providing valuable insights into metrics such as heart rate, steps taken, and sleep quality. However, accurately measuring blood pressure with wearables has remained particularly challenging. Traditional cuff-based methods temporarily restrict blood flow to measure pressure, a technique that is not easily replicated in a compact, wearable form. The challenges are multifold and have significantly impeded progress in this domain.

Traditional blood pressure cuffs are characteristically bulky and require precise positioning on the arm to ensure accuracy. Conversely, wearable devices are designed to be small and comfortable for constant wear, leading to compromises in measurement precision. This trade-off has meant that wearables, while convenient, fail to deliver the reliability of cuff-based readings. Wearables that do not restrict blood flow face obstacles in replicating the same level of precision and consistency, which in turn can lead to user mistrust of the data generated by these devices.

Moreover, wearables are intended for use during daily activities, which introduces another layer of complexity. Unlike controlled medical environments, where conditions can be carefully managed, wearables must contend with variable factors such as movement, posture changes, and physical exertion. These factors affect the accuracy of the readings and contribute to variability, making it difficult for wearables to gain the same level of trust and reliability as traditional and well-established methods. These challenges have thus necessitated a need for innovative solutions in the sector.

Advancements in Ultrasound Technology for Wearables

Novosound has tackled these challenges head-on by introducing miniaturized ultrasound technology embedded in a wearable device. This innovation is capable of monitoring blood pressure with the same level of accuracy as electronic cuff devices, setting a new standard in the industry. At the heart of Novosound’s breakthrough is continuous wave ultrasound sensors, a significant departure from the photoplethysmography (PPG) technology commonly used in consumer wearables.

PPG estimates blood flow by measuring changes in light absorption through the skin, a process prone to inaccuracy due to indirect measurement techniques that can be influenced by a variety of factors, such as skin tone and ambient light. In contrast, Novosound’s ultrasound sensors offer direct real-time measurement of arterial wall movements, thereby reducing inaccuracies associated with indirect methods and enhancing reliability for long-term health monitoring. This approach marks a substantial improvement, capable of providing continuous, cuffless, and wireless blood pressure tracking, which eliminates the need for bulky cuffs and significantly improves user comfort and convenience.

The Slanj wearable, as introduced by Novosound, integrates these advancements to provide an unprecedented level of accuracy and reliability in wearable blood pressure monitoring. Its cuffless design eliminates the need for periodic inflation and deflation, a process that can be uncomfortable and inconvenient for users. Instead, ultrasound technology affords continuous and unobtrusive monitoring, offering a seamless user experience. This balance of precision and user comfort represents a significant stride forward, presenting a viable solution to one of the most persistent challenges in the field.

Impact of Continuous Blood Pressure Monitoring in Healthcare

The Slanj device represents a significant leap forward in preventive healthcare, particularly by addressing undiagnosed hypertension with accessible, real-time health data. Continuous monitoring facilitates earlier detection of hypertension, which can greatly improve management and outcomes for individuals with this condition. This real-time data supports proactive healthcare interventions, potentially identifying and addressing health issues before they escalate.

Through continuous monitoring, healthcare providers can glean deeper insights into blood pressure trends, enabling more accurate and personalized treatment plans. Conditions such as white coat syndrome, where blood pressure readings are skewed due to the anxiety of clinical visits, benefit from data collected in everyday settings. This provides a true baseline for the patient’s health status, leading to better-informed clinical decisions. Additionally, the World Health Organization notes that over a billion adults globally suffer from hypertension, with many unaware of their condition. Continuous, real-time monitoring capabilities can bridge this gap, empowering individuals to take charge of their health more proactively.

By integrating real-time data into healthcare strategies, Slanj supports a more nuanced approach to hypertension management. For instance, the ability to monitor blood pressure continuously allows for the identification of patterns and potential triggers, such as stress or dietary habits. This data can inform personalized lifestyle changes, enhancing the effectiveness of health interventions. Moreover, the feedback provided can help to refine treatment plans, ensuring that the prescribed strategies are both appropriate and effective for the individual patient.

Novosound’s Slanj Wearable Device

The Slanj device, which was showcased at CES 2025, epitomizes a major evolution in health monitoring. It brings the ability to continuously and cufflessly monitor blood pressure to the forefront of wearable technology, significantly impacting the way hypertension is both diagnosed and managed. Leveraging advanced ultrasound technology, the device monitors arterial wall movement with a precision that surpasses traditional snapshot measurements, capturing dynamic changes in blood pressure that are crucial for accurate health assessments.

The miniaturization of ultrasound sensors enables the Slanj device to remain compact and comfortable enough for all-day use. Its wireless and cuffless design further enhances the user experience, fostering long-term adherence to health monitoring protocols without the discomfort associated with traditional blood pressure cuffs. This combination of precision and convenience heralds a promising tool for both patients and healthcare providers, providing valuable data that can lead to more effective and tailored treatment plans.

The benefits of the Slanj device extend beyond individual health monitoring. By collecting data continuously and in real-time, it has the potential to offer broader insights into population health trends. On a larger scale, this could inform public health strategies, identify emerging health issues, and optimize resource allocation. This transformative potential underscores the significant impact that wearable technologies like Slanj can have on the future of healthcare.

Transformative Potential for Hypertension Management

Novosound has revolutionized blood pressure monitoring by introducing their miniaturized ultrasound technology within a wearable device. This innovative method matches the accuracy of traditional electronic cuff devices, setting a new benchmark in the industry. Traditional consumer wearables often use photoplethysmography (PPG) technology, which estimates blood flow by measuring light absorption through the skin. PPG’s accuracy can be compromised by various factors such as skin tone and light conditions. In contrast, Novosound’s continuous wave ultrasound sensors measure arterial wall movements directly and in real-time, greatly reducing inaccuracies and enhancing reliability for long-term health tracking.

Novosound’s Slanj wearable leverages this breakthrough, offering an advanced, cuffless design that eliminates the need for periodic inflation and deflation. This process often found in traditional cuffs can be both uncomfortable and inconvenient for users. By using ultrasound technology, Slanj provides continuous and unobtrusive blood pressure monitoring, ensuring a seamless and comfortable experience. This blend of precision and user comfort marks significant progress, offering a practical solution to one of the most enduring challenges in the industry.

Subscribe to our weekly news digest.

Join now and become a part of our fast-growing community.

Invalid Email Address
Thanks for Subscribing!
We'll be sending you our best soon!
Something went wrong, please try again later